Trade Summary
2 days ago, Tatsis Ourania, serving as EVP, Chief Reg., Quality Offic at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 260 shares at $486.35 per share, for a total transaction value of $126,451.00. Following this transaction, Tatsis Ourania now holds 46,763 shares of VRTX.
This sale represents a 1.00% decrease in Tatsis Ourania's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.
Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.